Your browser doesn't support javascript.
loading
Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
McCabe, Sean Esteban; Figueroa, Olivia; McCabe, Vita V; Schepis, Ty S; Schulenberg, John E; Veliz, Philip T; Werner, Kennedy S; Wilens, Timothy E.
Afiliação
  • McCabe SE; Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor, MI, USA.
  • Figueroa O; Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor, MI, USA.
  • McCabe VV; University of Michigan, School of Medicine, Ann Arbor, MI, USA.
  • Schepis TS; Texas State University, San Marcos, TX, USA.
  • Schulenberg JE; University of Michigan - Institute for Social Research, Ann Arbor, MI, USA.
  • Veliz PT; University of Michigan-Systems, Populations, and Leadership, Ann Arbor, MI, USA.
  • Werner KS; Wayne State University School of Medicine-Psychiatry, Detroit, MI, USA.
  • Wilens TE; Harvard University-Psychiatry, Cambridge, MA, USA.
J Child Psychol Psychiatry ; 65(1): 100-111, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37062713
BACKGROUND: To assess whether age of onset and duration of stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) are associated with cocaine, methamphetamine, and prescription stimulant misuse during adolescence. METHODS: Nationally representative samples of US 10th and 12th grade students (N = 150,395) from the Monitoring the Future study were surveyed via self-administered questionnaires from 16 annual surveys (2005-2020). RESULTS: An estimated 8.2% of youth received stimulant therapy for ADHD during their lifetime (n = 10,937). More than one in 10 of all youth reported past-year prescription stimulant misuse (10.4%)-past-year cocaine (4.4%) and methamphetamine (2.0%) use were less prevalent. Youth who initiated early stimulant therapy for ADHD (≤9 years old) and for long duration (≥6 years) did not have significantly increased adjusted odds of cocaine or methamphetamine use relative to population controls (ie, non-ADHD and unmedicated ADHD youth). Youth who initiated late stimulant therapy for ADHD (≥10 years old) and for short duration (<1 year) had significantly higher odds of past-year cocaine or prescription stimulant misuse in adolescence than those initiating early stimulant therapy for ADHD (≤9 years old) and for long duration (≥6 years). Youth who initiated late stimulant therapy for ADHD (≥10 years) for short duration (<1 year) had significantly higher odds of past-year cocaine, methamphetamine, and prescription stimulant misuse versus population controls during adolescence. No differences in past-year cocaine, methamphetamine, and prescription stimulant misuse were found between individuals who only used non-stimulant therapy for ADHD relative to youth who initiated early stimulant therapy (≤9 years old) and for long duration (≥6 years). CONCLUSIONS: An inverse relationship was found between years of stimulant therapy and illicit and prescription stimulant misuse. Adolescents with later initiation and/or shorter duration of stimulant treatment for ADHD should be monitored for potential illicit and prescription stimulant misuse.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Cocaína / Transtornos Relacionados ao Uso de Substâncias / Estimulantes do Sistema Nervoso Central / Metanfetamina Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Revista: J Child Psychol Psychiatry Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Cocaína / Transtornos Relacionados ao Uso de Substâncias / Estimulantes do Sistema Nervoso Central / Metanfetamina Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Revista: J Child Psychol Psychiatry Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos